Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Envoy Medical Inc (COCH)

Envoy Medical Inc (COCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient

Event to Take Place December 11th at 4:30 P.M. ETWhite Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health...

COCH : 0.8457 (+4.06%)
Envoy Medical Announces the Grant of Its 40th U.S. Patent

New Patent Adds to Company's Growing Portfolio of Intellectual Property Focused on Fully Implanted Hearing DevicesWhite Bear Lake, Minnesota--(Newsfile Corp. - December 2, 2025) - Envoy Medical® Inc....

COCH : 0.8457 (+4.06%)
Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

Patent adds to Envoy Medical's expanding intellectual property portfolio, reinforcing the Company's leadership in next generation cochlear implant innovationWhite Bear Lake, Minnesota--(Newsfile Corp....

COCH : 0.8457 (+4.06%)
Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial

The trials expansion highlights the Company's clinical momentum and growing confidence in the device's adoption and Company's commercial strategyWhite Bear Lake, Minnesota--(Newsfile Corp. - November 18,...

COCH : 0.8457 (+4.06%)
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results

Transformational quarter puts Envoy Medical in significantly better position as it eliminated $32 million of debt, strengthened its balance sheet, and further expanded its patent portfolio; In addition,...

COCH : 0.8457 (+4.06%)
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

Rapid patient enrollment underscores strong market interest and reinforces commercialization opportunity for fully implanted cochlear implantsWhite Bear Lake, Minnesota--(Newsfile Corp. - November 4, 2025)...

COCH : 0.8457 (+4.06%)
Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant

The Company looks to build on its recent momentum - receiving FDA approval to expand its pivotal clinical trial into the second and final stageWhite Bear Lake, Minnesota--(Newsfile Corp. - October 29,...

COCH : 0.8457 (+4.06%)
Envoy Medical Receives Positive Listing Determination from NASDAQ

White Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions,...

COCH : 0.8457 (+4.06%)
Envoy Medical Raises $4 Million in Stock Offering

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Envoy Medical...

COCH : 0.8457 (+4.06%)
Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

$4 million upfront with up to additional $12 million of potential aggregate gross proceeds upon the exercise in full of warrantsWhite Bear Lake, Minnesota--(Newsfile Corp. - October 9, 2025) - Envoy Medical®...

COCH : 0.8457 (+4.06%)

Barchart Exclusives

Is This Dividend Stock a Buy for 2026 After Rising 265% in 2025?
Anglogold Ashanti shares have soared this year amid a spike in gold prices. While the shares might take a breather for now, it is a buy-on-the-dip candidate for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar